CAMP
Camp4 Therapeutics Corp · Healthcare · Market cap $206.5M
Insiders sold $2.4M net in the last 90 days ·2 sellers, 4 buyers· latest Form 4 filed Sep 2, 2026
Insider Buying
$99K
reported purchases (SEC code P)
Insider Selling
$2.5M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Sep 2, 2026
Gold Kelly
Camp4 Therapeutics Corp (CAMP) has 9 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Sep 2, 2026.
Inside the rolling window, 6 insiders at Camp4 Therapeutics Corp reported 5 open-market purchases totaling $99K and 6 open-market sales totaling $2.5M. The most active filer is Director Schwab Andrew J. with 5 filings. Insiders have net sold $2.4M over the trailing 6 months. The most recent open-market filing is a purchase of 10,000 shares by Chief Financial Officer Gold Kelly, dated Aug 31, 2026, worth $40K.
- Industry:Biotechnology
- CEO:Joshua Mandel-Brehm
- Employees:48
- HQ:Cambridge, MA, US
- IPO:2024-10-11
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Financial Officer | Purchase | 10,000 | $40K | Sep 2 | -13.4% | SEC ↗ | |
| Director | Sale | 400,000 | $1.6M | Aug 31 | -16.9% | SEC ↗ | |
| Director | Sale | 10 | $45 | Aug 26 | -21.7% | SEC ↗ | |
| Director | Sale | 45,147 | $215K | Aug 21 | -26.6% | SEC ↗ | |
| Director | Sale | 114,700 | $521K | Aug 21 | -26.6% | SEC ↗ | |
| Director | Sale | 32,018 | $144K | Aug 21 | -26.6% | SEC ↗ | |
Tardiff DanielFirst filing | Chief Scientific Officer | Sale | 1,738 | $8K | Aug 20 | -26.2% | SEC ↗ |
Gold KellyFirst filing | Chief Financial Officer | Purchase | 6,551 | $11K | Aug 5 | -18.0% | SEC ↗ |
Young Richard AFirst filing | Director | Purchase | 16,378 | $27K | Aug 5 | -18.0% | SEC ↗ |
Maricich YuriFirst filing | Chief Medical Officer | Purchase | 6,551 | $11K | Aug 5 | -18.0% | SEC ↗ |
Mandel-Brehm JoshFirst filing | Chief Executive Officer | Purchase | 6,551 | $11K | Aug 5 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does CAMP have?
Camp4 Therapeutics Corp (CAMP) has 9 SEC Form 4 filings (11 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Sep 2, 2026.
When was the most recent SEC Form 4 filing for CAMP?
The most recent Form 4 filing for CAMP on Tracefour is dated Sep 2, 2026.
Who is the most active insider at CAMP?
The most active SEC Form 4 filer at CAMP in the rolling window is Director Schwab Andrew J., with 5 filings.
What is the net insider flow at CAMP over the last 6 months?
Over the trailing 180 days, insiders at CAMP have net sold $2.4M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at CAMP in the current window?
Inside the rolling window, insiders at CAMP bought $99K and sold $2.5M based on SEC Form 4 filings.
Can I get alerts for CAMP insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Camp4 Therapeutics Corp (CAMP). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Camp4 Therapeutics Corp is in the Healthcare sector.